Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Effect of Vitamin D Supplementation on Markers of Vascular Function : A Systematic Review and Individual Participant Meta-Analysis. / Beveridge, Louise A; Khan, Faisel; Struthers, Allan D; Armitage, Jane; Barchetta, Ilaria; Bressendorff, Iain; Cavallo, Maria Gisella; Clarke, Robert; Dalan, Rinkoo; Dreyer, Gavin; Gepner, Adam D; Forouhi, Nita G; Harris, Ryan A; Hitman, Graham A; Larsen, Thomas; Khadgawat, Rajesh; Marckmann, Peter; Mose, Frank H; Pilz, Stefan; Scholze, Alexandra; Shargorodsky, Marina; Sokol, Seth I; Stricker, Hans; Zoccali, Carmine; Witham, Miles D.

In: Journal of the American Heart Association, Vol. 7, No. 11, e008273, 2018.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Beveridge, LA, Khan, F, Struthers, AD, Armitage, J, Barchetta, I, Bressendorff, I, Cavallo, MG, Clarke, R, Dalan, R, Dreyer, G, Gepner, AD, Forouhi, NG, Harris, RA, Hitman, GA, Larsen, T, Khadgawat, R, Marckmann, P, Mose, FH, Pilz, S, Scholze, A, Shargorodsky, M, Sokol, SI, Stricker, H, Zoccali, C & Witham, MD 2018, 'Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis', Journal of the American Heart Association, vol. 7, no. 11, e008273. https://doi.org/10.1161/JAHA.117.008273

APA

Beveridge, L. A., Khan, F., Struthers, A. D., Armitage, J., Barchetta, I., Bressendorff, I., Cavallo, M. G., Clarke, R., Dalan, R., Dreyer, G., Gepner, A. D., Forouhi, N. G., Harris, R. A., Hitman, G. A., Larsen, T., Khadgawat, R., Marckmann, P., Mose, F. H., Pilz, S., ... Witham, M. D. (2018). Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis. Journal of the American Heart Association, 7(11), [e008273]. https://doi.org/10.1161/JAHA.117.008273

Vancouver

Beveridge LA, Khan F, Struthers AD, Armitage J, Barchetta I, Bressendorff I et al. Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis. Journal of the American Heart Association. 2018;7(11). e008273. https://doi.org/10.1161/JAHA.117.008273

Author

Beveridge, Louise A ; Khan, Faisel ; Struthers, Allan D ; Armitage, Jane ; Barchetta, Ilaria ; Bressendorff, Iain ; Cavallo, Maria Gisella ; Clarke, Robert ; Dalan, Rinkoo ; Dreyer, Gavin ; Gepner, Adam D ; Forouhi, Nita G ; Harris, Ryan A ; Hitman, Graham A ; Larsen, Thomas ; Khadgawat, Rajesh ; Marckmann, Peter ; Mose, Frank H ; Pilz, Stefan ; Scholze, Alexandra ; Shargorodsky, Marina ; Sokol, Seth I ; Stricker, Hans ; Zoccali, Carmine ; Witham, Miles D. / Effect of Vitamin D Supplementation on Markers of Vascular Function : A Systematic Review and Individual Participant Meta-Analysis. In: Journal of the American Heart Association. 2018 ; Vol. 7, No. 11.

Bibtex

@article{aeb207fb5a9b443990e2c346c688064a,
title = "Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis",
abstract = "BACKGROUND: Low 25-hydroxyvitamin D levels are associated with an increased risk of cardiovascular events, but the effect of vitamin D supplementation on markers of vascular function associated with major adverse cardiovascular events is unclear.METHODS AND RESULTS: We conducted a systematic review and individual participant meta-analysis to examine the effect of vitamin D supplementation on flow-mediated dilatation of the brachial artery, pulse wave velocity, augmentation index, central blood pressure, microvascular function, and reactive hyperemia index. MEDLINE, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, and http://www.ClinicalTrials.gov were searched until the end of 2016 without language restrictions. Placebo-controlled randomized trials of at least 4 weeks duration were included. Individual participant data were sought from investigators on included trials. Trial-level meta-analysis was performed using random-effects models; individual participant meta-analyses used a 2-stage analytic strategy, examining effects in prespecified subgroups. 31 trials (2751 participants) were included; 29 trials (2641 participants) contributed data to trial-level meta-analysis, and 24 trials (2051 participants) contributed to individual-participant analyses. Vitamin D3 daily dose equivalents ranged from 900 to 5000 IU; duration was 4 weeks to 12 months. Trial-level meta-analysis showed no significant effect of supplementation on macrovascular measures (flow-mediated dilatation, 0.37% [95% confidence interval, -0.23 to 0.97]; carotid-femoral pulse wave velocity, 0.00 m/s [95% confidence interval, -0.36 to 0.37]); similar results were obtained from individual participant data. Microvascular function showed a modest improvement in trial-level data only. No consistent benefit was observed in subgroup analyses or between different vitamin D analogues.CONCLUSIONS: Vitamin D supplementation had no significant effect on most markers of vascular function in this analysis.",
author = "Beveridge, {Louise A} and Faisel Khan and Struthers, {Allan D} and Jane Armitage and Ilaria Barchetta and Iain Bressendorff and Cavallo, {Maria Gisella} and Robert Clarke and Rinkoo Dalan and Gavin Dreyer and Gepner, {Adam D} and Forouhi, {Nita G} and Harris, {Ryan A} and Hitman, {Graham A} and Thomas Larsen and Rajesh Khadgawat and Peter Marckmann and Mose, {Frank H} and Stefan Pilz and Alexandra Scholze and Marina Shargorodsky and Sokol, {Seth I} and Hans Stricker and Carmine Zoccali and Witham, {Miles D}",
note = "{\textcopyright} 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.",
year = "2018",
doi = "10.1161/JAHA.117.008273",
language = "English",
volume = "7",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "11",

}

RIS

TY - JOUR

T1 - Effect of Vitamin D Supplementation on Markers of Vascular Function

T2 - A Systematic Review and Individual Participant Meta-Analysis

AU - Beveridge, Louise A

AU - Khan, Faisel

AU - Struthers, Allan D

AU - Armitage, Jane

AU - Barchetta, Ilaria

AU - Bressendorff, Iain

AU - Cavallo, Maria Gisella

AU - Clarke, Robert

AU - Dalan, Rinkoo

AU - Dreyer, Gavin

AU - Gepner, Adam D

AU - Forouhi, Nita G

AU - Harris, Ryan A

AU - Hitman, Graham A

AU - Larsen, Thomas

AU - Khadgawat, Rajesh

AU - Marckmann, Peter

AU - Mose, Frank H

AU - Pilz, Stefan

AU - Scholze, Alexandra

AU - Shargorodsky, Marina

AU - Sokol, Seth I

AU - Stricker, Hans

AU - Zoccali, Carmine

AU - Witham, Miles D

N1 - © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.

PY - 2018

Y1 - 2018

N2 - BACKGROUND: Low 25-hydroxyvitamin D levels are associated with an increased risk of cardiovascular events, but the effect of vitamin D supplementation on markers of vascular function associated with major adverse cardiovascular events is unclear.METHODS AND RESULTS: We conducted a systematic review and individual participant meta-analysis to examine the effect of vitamin D supplementation on flow-mediated dilatation of the brachial artery, pulse wave velocity, augmentation index, central blood pressure, microvascular function, and reactive hyperemia index. MEDLINE, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, and http://www.ClinicalTrials.gov were searched until the end of 2016 without language restrictions. Placebo-controlled randomized trials of at least 4 weeks duration were included. Individual participant data were sought from investigators on included trials. Trial-level meta-analysis was performed using random-effects models; individual participant meta-analyses used a 2-stage analytic strategy, examining effects in prespecified subgroups. 31 trials (2751 participants) were included; 29 trials (2641 participants) contributed data to trial-level meta-analysis, and 24 trials (2051 participants) contributed to individual-participant analyses. Vitamin D3 daily dose equivalents ranged from 900 to 5000 IU; duration was 4 weeks to 12 months. Trial-level meta-analysis showed no significant effect of supplementation on macrovascular measures (flow-mediated dilatation, 0.37% [95% confidence interval, -0.23 to 0.97]; carotid-femoral pulse wave velocity, 0.00 m/s [95% confidence interval, -0.36 to 0.37]); similar results were obtained from individual participant data. Microvascular function showed a modest improvement in trial-level data only. No consistent benefit was observed in subgroup analyses or between different vitamin D analogues.CONCLUSIONS: Vitamin D supplementation had no significant effect on most markers of vascular function in this analysis.

AB - BACKGROUND: Low 25-hydroxyvitamin D levels are associated with an increased risk of cardiovascular events, but the effect of vitamin D supplementation on markers of vascular function associated with major adverse cardiovascular events is unclear.METHODS AND RESULTS: We conducted a systematic review and individual participant meta-analysis to examine the effect of vitamin D supplementation on flow-mediated dilatation of the brachial artery, pulse wave velocity, augmentation index, central blood pressure, microvascular function, and reactive hyperemia index. MEDLINE, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, and http://www.ClinicalTrials.gov were searched until the end of 2016 without language restrictions. Placebo-controlled randomized trials of at least 4 weeks duration were included. Individual participant data were sought from investigators on included trials. Trial-level meta-analysis was performed using random-effects models; individual participant meta-analyses used a 2-stage analytic strategy, examining effects in prespecified subgroups. 31 trials (2751 participants) were included; 29 trials (2641 participants) contributed data to trial-level meta-analysis, and 24 trials (2051 participants) contributed to individual-participant analyses. Vitamin D3 daily dose equivalents ranged from 900 to 5000 IU; duration was 4 weeks to 12 months. Trial-level meta-analysis showed no significant effect of supplementation on macrovascular measures (flow-mediated dilatation, 0.37% [95% confidence interval, -0.23 to 0.97]; carotid-femoral pulse wave velocity, 0.00 m/s [95% confidence interval, -0.36 to 0.37]); similar results were obtained from individual participant data. Microvascular function showed a modest improvement in trial-level data only. No consistent benefit was observed in subgroup analyses or between different vitamin D analogues.CONCLUSIONS: Vitamin D supplementation had no significant effect on most markers of vascular function in this analysis.

U2 - 10.1161/JAHA.117.008273

DO - 10.1161/JAHA.117.008273

M3 - Review

C2 - 29848497

VL - 7

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 11

M1 - e008273

ER -

ID: 222168759